WEEK 9 Discussion

docx

School

Grand Canyon University *

*We aren’t endorsed by this school

Course

9901

Subject

Nursing

Date

Nov 24, 2024

Type

docx

Pages

4

Uploaded by biancaflo

Report
1 WEEK 9: Discussion Student’s Name Institutional Affiliation Course Title Professor Date
2 Discussion: Women’s and Men’s Health, Infectious Disease, and Hematologic Disorders Patient Health Needs A.D. is a 46-year-old female with a history of HTN and ASCUS on her pap five years ago. The patient has a family history of breast cancer but is up to date on her annual mammograms. Her monthly menstrual cycles are regular. She uses HCTZ 25mg qd and Norvasc 10mg qd to manage her HTN. However, since last month she has not been feeling well, and she presents today with a BP of 150/90 and complains of night sweats, hot flushing, and genitourinary symptoms. The patient is in Stage I of high blood pressure and needs to take medications and make lifestyle changes (Liu & Zheng, 2017). Also, the patient's complaints indicate the development of the genitourinary syndrome of menopause (GSM) that needs to be managed (Angelou et al., 2020). Recommended Treatment Regimen Newson (2018) state that women in the early postmenopausal years are most at risk for hypertension, which is the most significant risk factor. According to Maas et al. (2021), mild to moderate HTN has the potential to cause complaints like sleep disturbances, hot flushes, non- specific chest pain, palpitations, headaches, depression, anxiety, and fatigue, among others. Compared to men, aging women see a steeper increase in systolic blood pressure, possibly due to menopausal hormonal changes (Newson, 2018). An additional significant change that occurs around menopause is a rise in insulin resistance, which has a negative impact on blood pressure, body weight, lipid metabolism, and the emergence of metabolic syndrome. Also, in recommending the optimal treatment regimen for the patient, it is important to consider that she is at high risk for breast cancer because of her family history. Maas et al. (2021) indicate that non-hormonal treatments should be provided as first-line treatments to women with breast cancer or at high risk for developing it in order to manage the genitourinary symptoms. For instance, they include lubricants, moisturizers, dilator therapy, and pelvic floor physical therapy.
3 Therefore, the recommended treatment regimen for the patient would be the use of clonidine 0.1 mg PO q12hr and gabapentin 400 mg qd. Clonidine will be used to help manage the genitourinary symptoms, as well as the rise in systolic blood pressure. Gabapentin will be used to help with night sweats and hot flashes (Hickey et al., 2017). The choice of these medications was possible because there were no interactions with the patient's current medications. Patient Education Strategy I will recommend that the patient maintain a heart-healthy diet, regularly engage in physical activities, maintain a healthy weight, and get enough sleep daily. According to Peacock et al. (2021), the need to undergo a bone scan and ensure the diet is rich in vitamin D and calcium. Also, the patient will be informed on refraining from taking untested products and rater to consult a health care provider. Also, I will educate the patient concerning the increased risk of cardiovascular diseases and how to prevent them. Additionally, the patient is susceptible to mood changes; thus, I will recommend that the patient seek a mental health nurse to get counsel. Additionally, the patient must learn about the physiology of menopause. According to World Health Organization (2022), the majority of women undergo menopause between 45 and 55 years as an indication of the natural portion of biological aging. With this knowledge, and our patient being 46 years, it is essential to educate the patient on how to cope with the symptoms. Therefore, the patient education strategy will involve understanding the current health condition, managing the condition, and preventing the development of commodities.
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
  • Access to all documents
  • Unlimited textbook solutions
  • 24/7 expert homework help
4 References Angelou, K., Grigoriadis, T., Diakosavvas, M., Zacharakis, D., & Athanasiou, S. (2020). The genitourinary syndrome of menopause: an overview of the recent data.  Cureus 12 (4).10.7759/cureus.7586 Hickey, M., Szabo, R. A., & Hunter, M. S. (2017). Non-hormonal treatments for menopausal symptoms.  Bmj 359 . https://doi.org/10.1136/bmj.j5101 Liu, P., & Zheng, J. G. (2017). Blood pressure targets in the hypertensive elderly.  Chinese Medical Journal 130 (16), 1968-1972. https://mednexus.org/doi/full/10.4103/0366-6999.211885 Maas, A. H., Rosano, G., Cifkova, R., Chieffo, A., van Dijken, D., Hamoda, H., ... & Collins, P. (2021). Cardiovascular health after menopause transition, pregnancy disorders, and other gynecologic conditions: a consensus document from European cardiologists, gynecologists, and endocrinologists. European Heart Journal 42 (10), 967-984. https://doi.org/10.1093/eurheartj/ehaa1044 Newson, L. (2018). Menopause and cardiovascular disease.  Post reproductive health 24 (1), 44- 49. https://doi.org/10.1177/2053369117749675 Peacock, K., Ketvertis, K. M., & Doerr, C. (2021). Menopause (Nursing). https://europepmc.org/article/nbk/nbk568694 World Health Organization. (2022). Menopause. Accessed on July 25, 2023, from: https://www.who.int/news-room/fact-sheets/detail/menopause#:~:text=Most%20women %20experience%20menopause%20between,in%20circulating%20blood%20oestrogen%20levels .